'Biosimilars market' presentation slideshows

Biosimilars market - PowerPoint PPT Presentation

Big Pharma?

Big Pharma?

Big Pharma?. Clotilde Bourdon Olivia Scaccia Pauline Fontaine Antoine Hennino t. Teva’s id. Headquarters : Petak Tikva , Israel Stock exchange : Nasdaq SEAQ International London Francfort

★ ★ ★ ★ ★

1.18k views • 69 slides
Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography)

Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography)

Biosimilars or follow-on-biologics are the “copied” version of reference biologics, which are protected by intellectual rights that will expire soon. Patent expiration is the major driving factor of the biosimilars market. Most of the blockbuster patents will expire by the end of 2014, which would provide a competitive edge to local pharmaceutical manufacturers over the global players.

★ ★ ★ ★ ★

350 views • 14 slides
World Biosimilars/Follow-on-Biologics - Market Opportunities and Forecast, 2014 - 2020

World Biosimilars/Follow-on-Biologics - Market Opportunities and Forecast, 2014 - 2020

Biosimilars or follow-on-biologics are highly similar versions of reference biologics derived from living organisms such as plants and animals. The development of biosimilars and validation with reference biologics play a significant role in the commercialization of biosimilars. Economic pricing of biosimilars, ease in development and a quick approval process are some key driving factors that drive the growth of this market. Effective and timely formulated regulations facilitate the viability and balance between original and biosimilar products. Moreover, a favorable regulatory environment and the establishment of IPR protections are factors that boost the market growth. The upcoming patent expiration for blockbuster drugs has revolutionized the aspect of commercialization whilst triggering a large scale adoption of biosimilars. Biosimilars industry is facing problems relating to production efficiency and quantity. Get More Information @https://www.alliedmarketresearch.com/global-biosimilars-market

★ ★ ★ ★ ★

309 views • 12 slides
Global Biosimilars/Follow-on-Biologics Market 2013-2020

Global Biosimilars/Follow-on-Biologics Market 2013-2020

To Get details: http://www.bigmarketresearch.com/biosimilars-market "Global Biosimilars/Follow-on-Biologics Market Size, Trend, Analysis, Report, Research, Technology, Applications, Services and Geography, Opportunity and Forecast 2013 - 2020: Big Market Research" Biosimilars or follow-on-biologics are the “copied” version of reference biologics, which are protected by intellectual rights that will expire soon. Patent expiration is the major driving factor of the biosimilars market. Most of the blockbuster patents will expire by the end of 2014, which would provide a competitive edge to local pharmaceutical manufacturers over the global players. For instance, patents for insulin glargine will expire by the end of this year, which would give an opportunity for the growth of insulin biosimilars market. Global biosimilars/follow-on-biologics market accounted for $1,358 million in 2013 and it is anticipated to generate $35,032 million by 2020, growing at a CAGR of 60.8% from 2014 to 2020.

★ ★ ★ ★ ★

504 views • 11 slides
Biosimilar Market Forecast by 2020 (/Follow-on-Biologics)

Biosimilar Market Forecast by 2020 (/Follow-on-Biologics)

Biosimilar Market (Follow-on-Biologics) Size, Share, Analysis, Trends, Growth, Demand, and Research Report 2014-2020 @ Big Market Research | Global Biosimilars/follow-on-biologics Market to generate an approximate revenue of $26,551.3 million by 2020, registering a CAGR of 49.1% from 2015 to 2020. Biosimilars or follow-on-biologics are highly similar versions of reference biologics derived from living organisms such as plants and animals. The development of biosimilars and validation with reference biologics play a significant role in the commercialization of biosimilars. Economic pricing of biosimilars, ease in development and a quick approval process are some key driving factors that drive the growth of this market. Read Full Report @ http://www.bigmarketresearch.com/global-biosimilars-market

★ ★ ★ ★ ★

735 views • 11 slides
Biosimilars Market worth $6.22 Billion by 2020

Biosimilars Market worth $6.22 Billion by 2020

The report segments the market on the basis of product, application, and region. Among various product types, the recombinant nonglycosylated protein segment is expected to account for the largest share of the market in 2015. However, the recombinant glycosylated protein segment is expected to grow at the highest CAGR during the forecast period.

★ ★ ★ ★ ★

217 views • 10 slides
Biosimilars Market worth $6.22 Billion by 2020

Biosimilars Market worth $6.22 Billion by 2020

The report segments the market on the basis of product, application, and region. Among various product types, the recombinant nonglycosylated protein segment is expected to account for the largest share of the market in 2015.

★ ★ ★ ★ ★

196 views • 10 slides
Biosimilars Market is Anticipated To Reach $41.7 Billion By 2024

Biosimilars Market is Anticipated To Reach $41.7 Billion By 2024

The global biosimilars market is anticipated to witness a marked growth during the period of 2016 to 2024. The most significant factor leading to the growth of this industry is the fact that major biological drugs are nearing the patent cliff.

★ ★ ★ ★ ★

141 views • 9 slides
Global Biosimilars/Follow-on-Biologics Market Size, Share

Global Biosimilars/Follow-on-Biologics Market Size, Share

Biosimilars or follow-on-biologics are the “copied” version of reference biologics, which are protected by intellectual rights that will expire soon. Patent expiration is the major driving factor of the biosimilars market. Most of the blockbuster patents will expire by the end of 2014, which would provide a competitive edge to local pharmaceutical manufacturers over the global players. For instance, patents for insulin glargine will expire by the end of this year, which would give an opportunity for the growth of insulin biosimilars market. Global biosimilars/follow-on-biologics market accounted for $1,358 million in 2013 and it is anticipated to generate $35,032 million by 2020, growing at a CAGR of 60.8% from 2014 to 2020. Get Full Report at: http://www.researchbeam.com/biosimilars-market

★ ★ ★ ★ ★

318 views • 8 slides
BIOSIMILARS - Regulatory Framework and Pipeline Analysis – Aarkstore.com

BIOSIMILARS - Regulatory Framework and Pipeline Analysis – Aarkstore.com

BIOSIMILARS- Regulatory Framework and Pipeline Analysis provides market dynamics, key players, therapy area, development phase, legal strategies, action mechanism, late stage products, competition prediction, indications, healthcare expenditure, trends, growth drivers, barriers, scope and a lot more.

★ ★ ★ ★ ★

280 views • 8 slides
Biosimilars Market - Global Industry Analysis and Forecast t

Biosimilars Market - Global Industry Analysis and Forecast t

Biosimilars or follow-on biologics are biopharmaceutical drugs that are similar to approved biological drugs. Biosimilars are different from other generic drugs in terms of raw material and their manufacturing process. Generic drugs are composed of small molecules. However, biosimilars are composed of more complex molecules, such as human insulin and monoclonal antibodies. Many biosimilars are derived from plants, animals, bacteria, viruses and yeast. It is produced by recombinant DNA technology and controlled gene expression methods. Biosimilar drugs are used in prevention and treatment of various severe diseases such as cancer, diabetes, autoimmune diseases, heart attacks, rheumatoid arthritis, oncology, growth hormone deficiency, chronic kidney failure, hematological disease and infectious disease. Biosimilars offer less costly treatment than other biological drugs and synthetic drugs.

★ ★ ★ ★ ★

278 views • 7 slides
Key Analysis Of Biosimilars Development Market

Key Analysis Of Biosimilars Development Market

Bigmarketresearch.com include new market research report “The Coming Age of Biosimilars - Regulatory developments and alliance strategies intensify interest in a developing market" To Get Complete Report Here @ http://www.bigmarketresearch.com/the-coming-age-of-biosimilars-regulatory-developments-and-alliance-strategies-intensify-interest-in-a-developing-market Biosimilars are attracting significant attention at present as companies from all sectors of the biopharmaceutical market are investigating the opportunities they present. Enquire About Report @ http://www.bigmarketresearch.com/report-enquiry/132480

★ ★ ★ ★ ★

212 views • 7 slides
Global Oncology Biosimilars Market 2015 Industry Growth, Trends, Analysis, Research and Development

Global Oncology Biosimilars Market 2015 Industry Growth, Trends, Analysis, Research and Development

Gathering and collating accurate data about the global Oncology Biosimilars market Research 2015 can be a hard task for companies operating in the market, due to the large volume of data about the market. Sifting through the wide-ranging information can be a tough task, which is where this market research report comes into the picture. Prepared by expert analysts with years of experience and spot-on market judgment, the report is a must-have accessory for all participants in the Oncology Biosimilars market.

★ ★ ★ ★ ★

181 views • 6 slides
Global Biosimilars Market Report

Global Biosimilars Market Report

Biosimilars are the biologics pharmaceutical drugs which are similar to the reference biologic products. These drugs are an interchangeable biological product that contains synthetically developed protein molecules. Visit Us : https://www.scalarmarketresearch.com/market-reports/biosimilars-market

★ ★ ★ ★ ★

191 views • 6 slides
Global Biosimilars industry size is expected to increase significantly by 2024

Global Biosimilars industry size is expected to increase significantly by 2024

The global biosimilars market size was valued at 3.39 billion in 2016 and is expected to grow on account of increasing prevalence of chronic diseases such as cancer and autoimmune disorders.

★ ★ ★ ★ ★

86 views • 6 slides
Biosimilars Market Research Report - Global Industry Analysis

Biosimilars Market Research Report - Global Industry Analysis

Biosimilars Industry is Expected to Grow on Account of Increasing Prevalence of Chronic Diseases

★ ★ ★ ★ ★

90 views • 6 slides
Global Biosimilars Market Is Expected To Reach US$ 25.83 Bn By 2025

Global Biosimilars Market Is Expected To Reach US$ 25.83 Bn By 2025

The Biosimilars  market was valued at US$ 3.52 Bn in 2016, and is expected to reach US$ 25.83 Bn by 2025, expanding at a CAGR of  23.1% from 2017 to 2025.

★ ★ ★ ★ ★

58 views • 4 slides
The global biosimilars market is expected to reach $6.22 Billion by 2020

The global biosimilars market is expected to reach $6.22 Billion by 2020

Biosimilars Market categories the Global Market by Application (Oncology, Blood Disorders), Product (Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Interferons, rHGH), Glycosylated (Monoclonal Antibodies, EPO), Peptides (Glucagon, Calcitonin)) & by Geograph

★ ★ ★ ★ ★

182 views • 3 slides
Biosimilars Market Product Type, Application and Specification Forecast to 2016-2021

Biosimilars Market Product Type, Application and Specification Forecast to 2016-2021

Biosimilars Market Includes in-depth analysis of Market Application, Size, Specification, Trends, Major Manufacturers and Business Strategies by Considering Types, Market Segmentation and Analysis.

★ ★ ★ ★ ★

65 views • 3 slides
biosimilars market

biosimilars market

biosimilars market

★ ★ ★ ★ ★

143 views • 2 slides

View Biosimilars market PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Biosimilars market PowerPoint presentations. You can view or download Biosimilars market presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.